Mitoxantrone Hydrochloride Liposome Combined With Rituximab and Lenalidomide (M+R2) in Patients With Relapsed and Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT05575973 · UNKNOWN
Trial details
- NCT number
- NCT05575973
- Sponsor
- Jianfeng Zhou
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-10
- Primary completion
- 2025-07-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.